389977469 SH 30431630 12/19/2004 12:00:00 AM C0000737 DIS Admission Date : 12/19/2004 Report Status : Discharge Date : 12/23/2004 ****** DISCHARGE ORDERS****** MEEDHEYSKUDZRO , LEENLEE C 360-93-28-7P31 Room : 3M-963 Service : PUL DISCHARGE PATIENT ON : 12/23/04 AT 05:00 PM CONTINGENT UPON Not Applicable WILL D / C ORDER BE USED AS THE D / C SUMMARY : YES Attending : SADDCHIRD , ALINE CHPIE , M.D. CODE STATUS : No CPR / C0007203dC0397419/ NC0021925on / No C0042397 /DISPOSITION : Home w/ services DISCHARGE MEDICATIONS : C0354688 2 PUFF INH QID PRN ShortnessC0013404ng VITAMIN C (C0043144CC000396800 MC0003968ALCIN ( CALCITONIN - SC0721702 SPRC0073994 Doses Required ( approximate ) : 1MAG CITRATE ( CITRATE OF MAGNESIA ) 3C0126774RS PO QC0126774COLACE C0009806ODIUM ) 100 MG PO TID GLYBURIDE 5 MG PC0282139SC0243237 12/21/04 LACTULOSE 30 MILLILITERS C0022957D IF : diarrhea SENNA TABLETS 2 TC0011991DC3232296160 MG PO QID StartC0037138 12/23 ) PRN Other : gas , upset stomach . TAMOXIFEN 20C05770C0235309ride NotC0039286rride added on 12/19/04 by SAPMOORES , NELL RILET , M.D. on order for LEVOFLOXACIN PO ( ref # 88006031 ) C1271155IOUS INTERACTION : TAMOXIFEN CITRATE and LEVOFLOXACIN Reason C0079589are MVI C0205404C0687133LS ( THERAP VITS / MINERALS ) 1 TAB PO QD PILOCARPINE 4% SOLUTION 1C3661835CAC0979545RAY INH BID NC3661835080 ( BRIMONIDINE TARTRATE ) 1 DROP OS BID Number of Doses Required ( approximate ) : 2 LEVOFLOXACIN 250 MG PO QD X 1 Days Starting Today ( 12/21 ) Food / Drug InteC0594452InsC0077768iron products a minimum of 2 hours before or after a levofloxacin or ciproC0282386e dose If oC0302583, please cycle ( hold 1 hr before to 2 hr aC0282386hours befoC0008809 after dairy products C0311131erridden : Override added on 12/19/04 by SAPMOORES , NELL RILET , M.D. POTENTIALLY SERIOUS INTERACTION : TAMOXIFEN CITRATE and LEVOFLOXACIN Reason for override : aware CELEXA ( CITALOPRAM ) 20 MG PO QD CALCIUM CARB + D (C0079589VIT D/200 IU )C0282386D LUMIGAN ( BIMATOPROST 0.03% ) 1 DROPC0205404C0692710trictionC0719097tolerated FOLLOW UP APPOINTMENT ( S ) : Dr. FaC0719199rC0008845chbreunjesc , Dr. Roziesc , ALLERGY : CEFUROXIME C3853260ILADMIT DIAGNOSIS : abdominC0939372 PC0937917SCHARGE DIAGNOSIS ; Responsible After Study for Causing Admission ) abdomiC0007562THER DIAGNOSIS ; ConditionsC0000737, Complications , affecting Treatment / Stay Allergies - PCN - rash - Bactrim - hives -C0000737sea - Ceclor - nausea - Clarythro = rash OPERATIONS AND PROCEDURES : None . OTHER TREATMENTS /C3539909ES (C02208C001523C0591139. C0042109C0014806REC0027497FC0007537TC0027497RC0055856/o FC0015230hx poliomyelitis , breast CA stable on tamoxifen , vent dependent in an iron lung admitted w/ 1 day hx of abdominal pain . Pt was rC0032371ted 1 weC0006142 epigastric C0039286in wC2911574ment . SheC0559400fever , BRBPR , melena , dysuC0000737ion , T 97.5 , HR 86 , BP 111/47 , R 20 . Sat 94C0232493notable foC0030193peractive bowel sounds with abC0015967ion C0018932C0025222eC0013428alpation at LLQ C0204688nC0034107C0005824Q . C144339C0523807rebCUI-lC0031809d or guarC0232694ble findings compared C0000731cept for diC0234233ght colon consistent with ileus . HoC0234246couC0427198 : C0412620os;s clinical picture was consC0030247th coC0230180ipation-related abdominal pain . pt was startC4019039 bowel regimen with Senna , magcitrate and C0012359 .C1305188ose bowel movements were induced with above regimen . Her abd C0150155d tendernesC3489575C0126774r C00098067 . IC0332281007370mg x 3 days for UTI ( pyuria on admisstion ) C0000731en using iron lC0234233eathing and has been satting well duing her hosC0282386l course . Code C00420C0034359 DNI . ADDITIONAL COMMENTS : DISCHARGE CONC0559400Stable TO DO / PLAN : 1. Please follow up with Dr. Faleschird , Dr. Cuchbreunjesc and Dr. Roziesc . No dictated summary ENTERED BY : LEESEPLASSBREAN , RIDELT , M.D. ( FR98 ) 12/23/04 04:37 PM ****** END OF DISCHARGE ORDERS ******